These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 3037608)
1. Biosynthesis, characterization and inhibition of leukotriene B4 in human whole blood. Patrignani P; Canete-Soler R Prostaglandins; 1987 Apr; 33(4):539-51. PubMed ID: 3037608 [TBL] [Abstract][Full Text] [Related]
2. Radioimmunoassay of LTB4 and 6-trans LTB4: analytical and pharmacological characterisation of immunoreactive LTB4 in ionophore stimulated human blood. Carey F; Forder RA Prostaglandins Leukot Med; 1986 Apr; 22(1):57-70. PubMed ID: 3012587 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of leukotriene B4 formation in human neutrophils after oral nafazatrom (Bay g 6575). Strasser T; Fischer S; Weber PC Biochem Pharmacol; 1985 Jun; 34(11):1891-4. PubMed ID: 2988560 [TBL] [Abstract][Full Text] [Related]
4. Oral nafazatrom in man: effect on inhaled antigen challenge. Fuller RW; Maltby N; Richmond R; Dollery CT; Taylor GW; Ritter W; Philipp E Br J Clin Pharmacol; 1987 Jun; 23(6):677-81. PubMed ID: 3038156 [TBL] [Abstract][Full Text] [Related]
5. Release of leukotrienes into the perfusate of calcium-ionophore stimulated rabbit lungs. Influence of 5-lipoxygenase inhibitors. Schulz R; Seeger W Biochem Pharmacol; 1986 Jan; 35(2):183-93. PubMed ID: 3002385 [TBL] [Abstract][Full Text] [Related]
6. Leukotriene B4 production by stimulated whole blood: comparative studies with isolated polymorphonuclear cells. Gresele P; Arnout J; Coene MC; Deckmyn H; Vermylen J Biochem Biophys Res Commun; 1986 May; 137(1):334-42. PubMed ID: 3013186 [TBL] [Abstract][Full Text] [Related]
7. The effects of phosphodiesterase type 4 inhibitors on tumour necrosis factor-alpha and leukotriene B4 in a novel human whole blood assay. Brideau C; Van Staden C; Styhler A; Rodger IW; Chan CC Br J Pharmacol; 1999 Feb; 126(4):979-88. PubMed ID: 10193778 [TBL] [Abstract][Full Text] [Related]
8. Radioimmunoassay of LTB4 in plasma from different species: a cautionary note. Carey F; Forder RA; Gibson KH; Haworth D Prostaglandins Leukot Essent Fatty Acids; 1989 Apr; 36(1):57-61. PubMed ID: 2544898 [TBL] [Abstract][Full Text] [Related]
9. Ca2+ ionophore A23187-stimulated secretion of azurophil granules in human polymorphonuclear leukocytes is largely mediated by endogenously formed leukotriene B4. Hatzelmann A; Fruchtmann R; Mohrs KH; Raddatz S; Müller-Peddinghaus R Biochem Pharmacol; 1994 Jul; 48(1):31-9. PubMed ID: 8043028 [TBL] [Abstract][Full Text] [Related]
10. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models. Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987 [TBL] [Abstract][Full Text] [Related]
11. Effect of Zileuton (A-64077) on the 5-lipoxygenase activity of human whole blood ex vivo. Sirois P; Borgeat P; Lauzière M; Dubé L; Rubin P; Kesterson J Agents Actions; 1991 Sep; 34(1-2):117-20. PubMed ID: 1665285 [TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 inhibits and indomethacin and aspirin enhance, A23187-stimulated leukotriene B4 synthesis by rat peritoneal macrophages. Elliott GR; Lauwen AP; Bonta IL Br J Pharmacol; 1989 Feb; 96(2):265-70. PubMed ID: 2538186 [TBL] [Abstract][Full Text] [Related]
13. Immunologic and ionophore-induced generation of leukotriene B4 from mouse bone marrow-derived mast cells. Mencia-Huerta JM; Razin E; Ringel EW; Corey EJ; Hoover D; Austen KF; Lewis RA J Immunol; 1983 Apr; 130(4):1885-90. PubMed ID: 6300233 [TBL] [Abstract][Full Text] [Related]
14. Lipoxins A4 and B4 inhibit leukotriene B4 generation from human neutrophil leukocyte suspensions. Conti P; Reale M; Barbacane RC; Bongrazio M; Panara MR Immunol Lett; 1990 Jul; 24(4):237-42. PubMed ID: 2167876 [TBL] [Abstract][Full Text] [Related]
17. Impaired leukotriene B4 release by neonatal polymorphonuclear leukocytes. Viggiano D; Romano G; Caniglia M; Santoro P; Palumbo A; Ciccimarra F Pediatr Res; 1994 Jul; 36(1 Pt 1):60-3. PubMed ID: 7936838 [TBL] [Abstract][Full Text] [Related]
18. Leukotriene B4 production in human mononuclear phagocytes is modulated by interleukin-4-induced 15-lipoxygenase. Profita M; Sala A; Siena L; Henson PM; Murphy RC; Paternò A; Bonanno A; Riccobono L; Mirabella A; Bonsignore G; Vignola AM J Pharmacol Exp Ther; 2002 Mar; 300(3):868-75. PubMed ID: 11861792 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of leukotriene B4 (LTB4) in human neutrophils by L-threo-dihydrosphingosine. Darges JW; Robinson SP; Adams LM Adv Exp Med Biol; 1997; 400A():387-92. PubMed ID: 9547581 [TBL] [Abstract][Full Text] [Related]
20. Oxidation of leukotrienes at the omega end: demonstration of a receptor for the 20-hydroxy derivative of leukotriene B4 on human neutrophils and implications for the analysis of leukotriene receptors. Clancy RM; Dahinden CA; Hugli TE Proc Natl Acad Sci U S A; 1984 Sep; 81(18):5729-33. PubMed ID: 6091105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]